(Q47350709)

14 January 2018

title

Coronary thrombolysis with tissue-type plasminogen activator (t-PA): emerging strategies (English)

1 reference

14 January 2018

1 reference

1 reference

B E Sobel

1

1 reference

14 January 2018

language of work or name

English

0 references

publication date

1 November 1986

1 reference

14 January 2018

Journal of the American College of Cardiology

published in

1 reference

14 January 2018

volume

8

1 reference

14 January 2018

issue

5

1 reference

14 January 2018

page(s)

1220-1225

1 reference

14 January 2018

THE FIBRINOLYTIC ACTIVITY OF HEMOLYTIC STREPTOCOCCI.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980404-1

7 January 2021

Fibrinolysis in the animal organism

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980404-1

7 January 2021

Acute myocardial infarction: Intracoronary application of nitroglycerin and streptokinase

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980404-1

7 January 2021

Australian multicentre trial of streptokinase in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980404-1

7 January 2021

Factors influencing infarct size following experimental coronary artery occlusions

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980404-1

7 January 2021

Thrombolytic therapy in patients with acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980404-1

7 January 2021

Coronary thrombolysis: some unresolved issues

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980404-1

7 January 2021

The time course and characterization of myocardial hemorrhage after coronary reperfusion in the anesthetized dog

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980404-1

7 January 2021

Temporal dependence of beneficial effects of coronary thrombolysis characterized by positron tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980404-1

7 January 2021

Systemic thrombolytic therapy of acute myocardial infarction?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980404-1

7 January 2021

Clot-selective coronary thrombolysis with tissue-type plasminogen activator

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980404-1

7 January 2021

Coronary thrombolysis with tissue-type plasminogen activator in patients with evolving myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980404-1

7 January 2021

Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980404-1

7 January 2021

Coronary thrombolysis with intravenously administered human tissue-type plasminogen activator produced by recombinant DNA technology

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980404-1

7 January 2021

The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980404-1

7 January 2021

Thrombolysis, clot selectivity, and kinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980404-1

7 January 2021

Clinical pharmacology in patients with evolving myocardial infarction of tissue-type plasminogen activator produced by recombinant DNA technology

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980404-1

7 January 2021

Pharmacodynamics of tissue-type plasminogen activator characterized by computer-assisted simulation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980404-1

7 January 2021

Prevention of coronary thrombosis with subthrombolytic doses of tissue-type plasminogen activator.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980404-1

7 January 2021

Enhancement of salvage of reperfused ischemic myocardium by diltiazem

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980404-1

7 January 2021

Coronary thrombolysis with facilitated absorption of intramuscularly injected tissue-type plasminogen activator

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980404-1

7 January 2021

Early detection of myocardial infarction in conscious dogs by analysis of plasma MM creatine kinase isoforms

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980404-1

7 January 2021

Early detection of myocardial reperfusion by assay of plasma MM-creatine kinase isoforms in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980404-1

7 January 2021

Positron emission tomography of the heart

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980404-1

7 January 2021

10.1016/S0735-1097(86)80404-1

Identifiers

DOI

1 reference

14 January 2018

1 reference

14 January 2018